Back to results
US 5,204,328 AGranted
Peptides having atrial natriuretic factor activity
AssigneeMerck & Co., Inc.
InventorsRuth F. Nutt, Stephen F. Brady, Daniel F. Veber, Theresa M. Williams
Life of this patent
Estimating the term…
Abstract
Atrial natriuretic factor analogs containing N-alkylated amino acids and showing enhanced potency and increased metabolic stability. These analogs have natriuretic, diuretic and vasorelaxant activity, making them suitable for treating congestive heart failure and renal hypertension.
Claims13
A peptide having the amino acid sequence:
- ##STR13## wherein R is H, Ac, Ser, Ser-Ser, Arg-Ser-Ser, Arg-Arg-Ser-Ser, or Ser-Leu-Arg-Arg-Ser-Ser;
- A is Phe or N-MePhe;
- B is Gly, D/L-Ala or D/L-Pro;
- C is Gly, L-Ala or D/L-Pro;
- or
- B-C is ##STR14## where n=1 or 2, and
- R.sup.1 is H or methyl;
- D is Arg, N-MeArg or D/L-Pro;
- E is Arg, N-MeArg or Pro;
- F is Gly, D/L-Ala or D/L-Pro;
- G is Ala, N-MeAla or D/L-Pro, or
- F-G is ##STR15## wherein n=1 or 2, and
- R.sup.1 is H or methyl;
- H is Gln or D/L-Pro;
- I is Gly, D/L-Ala or D/L-Pro;
- J is Gly, D/L-Ala or D/L-Pro;
- K is D/L-Asn, D/L-Pro or D/L-N-MeAla;
- L is D/L-Ser, D/L-Pro or D/L-N-MeAla;
- M is D/L-Phe, D/L-N-MePhe or D/L-Pro;
- N is Met, Ile, Leu or Nle
- O is Asp or Glu;
- P is D/L-Arg, NH.sub.2 or is absent;
- Q is D/L-Tyr, NH.sub.2 or is absent;
- with the proviso that one residue of said peptide shall be N-methylated, said N-methylated residue taken from the group consisting of N-MePhe at position A, N-MeArg at position D, N-MeArg at position E, N-MeAla at position G, D/L-N-MeAla at position K, D/L-N-MeAla at position L and D/L-N-MePhe at position M;
- with the additional proviso that, when all other residue positions are identical to native ANP, M is not N-MePhe, K is not Pro or C is not Pro.
22 more elements
Dependencies are inferred from the claim text.